MUSE Drug Patent Profile
✉ Email this page to a colleague
When do Muse patents expire, and what generic alternatives are available?
Muse is a drug marketed by Mylan Speciality Lp and is included in one NDA.
The generic ingredient in MUSE is alprostadil. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the alprostadil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Muse
A generic version of MUSE was approved as alprostadil by HIKMA on January 20th, 1998.
Summary for MUSE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 104 |
Patent Applications: | 4,457 |
Drug Prices: | Drug price information for MUSE |
What excipients (inactive ingredients) are in MUSE? | MUSE excipients list |
DailyMed Link: | MUSE at DailyMed |
Pharmacology for MUSE
Drug Class | Prostaglandin Analog Prostaglandin E1 Agonist |
Mechanism of Action | Prostaglandin Receptor Agonists |
Physiological Effect | Genitourinary Arterial Vasodilation Venous Vasodilation |
Anatomical Therapeutic Chemical (ATC) Classes for MUSE
US Patents and Regulatory Information for MUSE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Speciality Lp | MUSE | alprostadil | SUPPOSITORY;URETHRAL | 020700-001 | Nov 19, 1996 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mylan Speciality Lp | MUSE | alprostadil | SUPPOSITORY;URETHRAL | 020700-004 | Nov 19, 1996 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mylan Speciality Lp | MUSE | alprostadil | SUPPOSITORY;URETHRAL | 020700-002 | Nov 19, 1996 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MUSE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Mylan Speciality Lp | MUSE | alprostadil | SUPPOSITORY;URETHRAL | 020700-003 | Nov 19, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
Mylan Speciality Lp | MUSE | alprostadil | SUPPOSITORY;URETHRAL | 020700-001 | Nov 19, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
Mylan Speciality Lp | MUSE | alprostadil | SUPPOSITORY;URETHRAL | 020700-003 | Nov 19, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MUSE
See the table below for patents covering MUSE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 4199489 | ⤷ Try a Trial | |
Ireland | 892680 | ⤷ Try a Trial | |
Australia | 655420 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |